Results 101 to 110 of about 38,436 (213)

The Evaluation of Thrombospondin 1 Levels in Patients with Acromegaly

open access: yesİstanbul Medical Journal, 2020
Introduction:Acromegaly is a rare disease caused by overproduction of growth hormone (GH) secreted from a benign pituitary adenoma. It has been shown in many studies that the incidence of cancer is increased in patients with acromegaly with increased GH ...
Mustafa Demirpençe   +5 more
doaj   +1 more source

Determinants of morbidities and mortality in acromegaly

open access: yesArchives of Endocrinology and Metabolism, 2019
Acromegaly is a systemic disease associated with increased morbidity, presenting cardiovascular, metabolic, respiratory, neoplastic, endocrine, articular and bone complications.
L. Kasuki   +3 more
semanticscholar   +1 more source

Cardiovascular System Changes and Related Risk Factors in Acromegaly Patients: A Case-Control Study

open access: yesInternational Journal of Endocrinology, 2015
Background. Cardiovascular complications are known to be the main determinants of reduced life expectancy and decreased quality of life in acromegaly patients.
Xiaopeng Guo   +10 more
doaj   +1 more source

3D Facial Analysis in Acromegaly: Gender-Specific Features and Clinical Correlations

open access: yesFrontiers in Endocrinology, 2018
Objective: Quantitative investigations of facial changes in acromegaly are rare. A new imaging technique, three-dimensional (3D) stereophotography, can accurately quantify whole facial changes.
Xiaopeng Guo   +21 more
doaj   +1 more source

Three-Dimensional Speckle-Tracking Echocardiography-Derived Tricuspid Annular Properties in Acromegaly—Results from the MAGYAR-Path Study

open access: yesBiomedicines
Introduction. Acromegaly is an endocrine pathology characterized by the overproduction of human growth hormone. The present study aimed to analyze three-dimensional speckle-tracking echocardiography (3DSTE)-derived tricuspid annular (TA) properties in ...
Attila Nemes   +6 more
doaj   +1 more source

Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study.

open access: yesEuropean Journal of Endocrinology, 2018
CONTEXT New therapeutic strategies have developed for the management of acromegaly over recent decades. Whether this has improved mortality has not been fully elucidated. OBJECTIVE The primary aim was to investigate mortality in a nationwide unselected
D. Esposito   +5 more
semanticscholar   +1 more source

MANAGEMENT OF ENDOCRINE DISEASE: Personalized medicine in the treatment of acromegaly.

open access: yesEuropean Journal of Endocrinology, 2018
Acromegaly is associated with high morbidity and elevated mortality when not adequately treated. Surgery is the first-line treatment for most patients as it is the only one that can lead to immediate cure.
L. Kasuki, L. E. Wildemberg, M. Gadelha
semanticscholar   +1 more source

THE TREATMENT OF ACROMEGALY [PDF]

open access: bronze, 1949
Lewis M. Hurxthal   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy